Gene transfer by cationic surfactants is essentially limited by the trapping of the surfactant/DNA complexes onto the cell membrane: a fluorescence investigation.
The interaction between complexes of plasmid DNA with cetyltrimethylammonium bromide (CTAB) and L929 fibroblasts was first examined using confocal microscopy. The complexes labeled with the DNA intercalator, YOYO-1, were found to be trapped onto the external face of the plasma membrane; a feature that may constitute a major limiting step in transfection. Moreover, since no cytotoxic effect appeared in these conditions, we further inferred that the CTAB molecules remained bound to the DNA. The interaction of the complexes with the membranes was best modeled with neutral vesicles. From anisotropy thermotropic curves of DPHpPC-labeled vesicles and fluorescence resonance energy transfer measurements between these vesicles and YOYO-labeled complexes, we evidenced that the binding of the complexes to the vesicle surface opened the micelle-like domains and unwound DNA. However, DNA was not released but remained stably bound via electrostatic interactions to the CTAB molecules incorporated in the external liposome leaflet. Consequently, the large diameter of the unwound plasmid DNA is likely the major factor that precludes its internalization into the cells by endocytosis. In contrast, anionic vesicles that mimic the cytoplasmic facing monolayer of the plasma membrane rapidly released DNA from the complex. This may explain the previously reported high transfection efficiency of DNA complexed with liposomes composed of neutral lipids and cationic surfactants, since the latter may destabilize the endosomal membrane and induce the release of DNA in the cytoplasm.
Clamme
J P
JP
Laboratoire Pharmacologie et physico-chimie des interactions cellulaires et moléculaires', UMR 7034 du CNRS, Faculté de Pharmacie, Université Louis Pasteur de Strasbourg, Illkirch, France.
Bernacchi
S
S
Vuilleumier
C
C
Duportail
G
G
Mély
Y
Y
D000818:Animals; D001583:Benzoxazoles; D002412:Cations; D002460:Cell Line; D002462:Cell Membrane / Q000737:chemistry; D000077286:Cetrimonium; D002593:Cetrimonium Compounds; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004247:DNA / Q000008:administration & dosage / Q000737:chemistry* / Q000235:genetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D007364:Intercalating Agents; D008081:Liposomes; D051379:Mice; D008823:Micelles; D018613:Microscopy, Confocal; D008958:Models, Molecular; D011806:Quinolinium Compounds; D013050:Spectrometry, Fluorescence; D013501:Surface-Active Agents
D001583:Benzoxazoles; D002412:Cations; D002593:Cetrimonium Compounds; D007364:Intercalating Agents; D008081:Liposomes; D008823:Micelles; D011806:Quinolinium Compounds; D013501:Surface-Active Agents; C075296:1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium; D004247:DNA; D000077286:Cetrimonium